JP Morgan Day 1: Biotech bonanza brings bankers to banquet
This article was originally published in Scrip
Executive Summary
Both early- and late-stage drug developers presented pipeline updates to standing room-only crowds of investment managers and high-net worth individuals at JP Morgan's annual gathering for health care-leaning investors in San Francisco on 13 January in light of big returns certain companies provided to investors in 2013.